Häufiger als gedacht – ein Update zu Dysphagie bei Multipler
                    Sklerose

Carolin Eckardt; Sabine Ulrike Vay; Clemens Warnke; Pia Flossdorf; Melanie Weinert

doi:10.1055/a-2216-9704

neuroreha, Inhaltsverzeichnis

neuroreha 2024; 16(01): 34-46
DOI: 10.1055/a-2216-9704

Schwerpunkt

Häufiger als gedacht – ein Update zu Dysphagie bei Multipler Sklerose

Carolin Eckardt

,

Sabine Ulrike Vay

,

Clemens Warnke

,

Pia Flossdorf

,

Melanie Weinert

Abstract

In Deutschland sind schätzungsweise mehr als 280 000 Menschen an Multipler Sklerose (MS) erkrankt. Neben sensiblen, motorischen, vegetativen und neuropsychologischen Funktionsstörungen ist die Dysphagie ein hochrelevantes, stark beeinträchtigendes und zugleich bislang nicht gut untersuchtes Symptom der Erkrankung. Der Artikel bietet eine Übersicht über die aktuelle Studienlage zur Dysphagie bei MS und soll die Wahrnehmung für das Symptom Schluckstörung im Kontext der MS-Erkrankung schärfen. Techniken zur weiterführenden Diagnostik und Therapie werden vorgestellt mit dem langfristigen Ziel, betroffene Menschen mit MS künftig zuverlässiger zu diagnostizieren, ihnen optimierte Hilfe zu bieten und ihre Lebensqualität zu verbessern.

Volltext

Referenzen

Literatur
1 Browne P, Chandraratna D, Angood C. et al. Atlas of multiple sclerosis 2013: A growing global problem with widespread inequity. Neurology 2014; 83: 1022-1024 DOI:10.1212/WNL.0000000000000768
2 Montalban X, Gold R, Thompson AJ. et al. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler J 2018; 24: 96-120 DOI:10.1177/1352458517751049
3 Was ist MS? | DMSG. Im Internet: https://www.dmsg.de/multiple-sklerose/was-ist-ms# Stand: 17.11.2023
4 Cree BAC, Gourraud PA, Oksenberg JR. et al. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol 2016; 80: 499-510 DOI:10.1002/ana.24747
5 Kappos L, Wolinsky JS, Giovannoni G. et al. Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials. JAMA Neurology 2020; 77: 1132-1140 DOI:10.1001/jamaneurol.2020.1568
6 Thompson AJ, Banwell BL, Barkhof F. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17: 162-173 DOI:10.1016/S1474-4422(17)30470-2
7 Montalban X, Hauser SL, Kappos L. et al. Ocrelizumab versus placebo inprimary progressive multiple sclerosis. N Engl J Med 2017; 376: 209-220 DOI:10.1056/NEJMoa1606468
8 Kappos L, Bar-Or A, Cree BAC. [Expand Clinical Investigators]. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): A double-blind, randomised, phase 3 study. Lancet 2018; 391: 1263-1273 DOI:10.1016/S0140-6736(18)30475-6
9 Prosiegel M, Weber S. Dysphagie: Diagnostik und Therapie; ein Wegweiser für kompetentes Handeln. 3. Aufl. Berlin: Springer; 2018
10 Hemmer B. et al. Diagnose und Therapie der Multiplen Sklerose, Neuromyelitis-optica-Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen, S2k-Leitlinie, 2023. In: Deutsche Gesellschaft für Neurologie; Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. Im Internet: www.dgn.org/leitlinien Stand: 27.09.2023
11 Dziewas R, Pflug C. et al. Neurogene Dysphagie, S1-Leitlinie, 2020. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. 1-115 Im Internet: www.dgn.org/leitlinien Stand: 27.09.2023
12 D’Amico E, Zanghì A, Serra A. et al. Management of dysphagia in multiple sclerosis: Current best practice. Expert Rev Gastroenterol Hepatol 2019; 13: 47-54 DOI:10.1080/17474124.2019.1544890
13 Inoue M. The neural mechanisms underlying swallowing title. Brain and Nerve 2015; 67: 157-168 DOI:10.11477/mf.1416200108
14 Warnecke T, Dziewas R. Neurogene Dysphagien: Diagnostik und Therapie. Stuttgart: Kohlhammer; 2018
15 Hamdy S, Aziz Q, Rothwell JC. et al The cortical topography of human swallowing musculature in health and disease. Nat Med. 1996 2. 1217-1224 Im Internet: http://www.nature.com/articles/nm1196-1217 Stand: 16.11.2023
16 Mihai PG, Otto M, Platz T. et al. Sequential evolution of cortical activity and effective connectivity of swallowing using fMRI. Hum Brain Mapp 2014; 35: 5962-5973 DOI:10.1002/hbm.22597
17 Calcagno P, Ruoppolo G, Grasso MG. et al. Dysphagia in multiple sclerosis: Prevalence and prognostic factors. Acta Neurol Scand 2002; 105: 40-43 DOI:10.1034/j.1600-0404.2002.10062.x
18 Jovana IB, Sarlota MT, Ivan NP. et al. Unilateral left frontal lobe lesion in a Marburg’s variant of multiple sclerosis patient with impaired swallowing and speech: A 3-year clinical/brain MRI follow-up. Neurology India 2022; 70: 1226-1229 DOI:10.4103/0028-3886.349594
19 Pawlitzki M, Neumann J, Kaufmann J. et al. Loss of corticospinal tract integrity in early MS disease stages. Neurol Neuroimmunol Neuroinflamm 2017; 4: 399 DOI:10.1212/NXI.0000000000000399
20 Kapitza C, Chunder R, Scheller A. et al. Murine esophagus expresses glial-derived central nervous system antigens. International Journal of Molecular Sciences 2021; 22: 3233 DOI:10.3390/ijms22063233
21 Alali D, Ballard K, Vucic S. et al. Dysphagia in multiple sclerosis: Evaluation and validation of the DYMUS questionnaire. Dysphagia 2018; 33: 273-281 DOI:10.1007/s00455-017-9864-5
22 Deutsche Multiple Sklerose Gesellschaft Bundesverband e.V. aktiv! (DMSG Bundesverband e.V.). 2018; 261: 22–23. Im Internet: https://www.dmsg.de/ Stand: 17.11.2023
23 Johansson K, Schalling E, Hartelius L. Self-reported changes in cognition, communication and swallowing in multiple sclerosis: Data from the Swedish Multiple Sclerosis Registry and from a national survey. Folia Phoniatrica et Logopaedica 2020; 1-13 DOI:10.1159/000505063
24 Piloti DTW, Ruiz VCD, de Ribeiro MC. et al. Association between clinical evaluation and self perception of deglutition with motor disability scale in patients with multiple sclerosis. CoDAS 2022; 34: e20210026 DOI:10.1590/2317-1782/20212021026
25 Printza A, Triaridis S, Kalaitzi M. et al. Dysphagia prevalence, attitudes, and related quality of life in patients with multiple sclerosis. Dysphagia 2020; 35: 677-684 DOI:10.1007/s00455-019-10075-0
26 Guan XL, Wang H, Huang HS. et al. Prevalence of dysphagia in multiple sclerosis: A systematic review and meta-analysis. Neurol Sci 2015; 36: 671-681 DOI:10.1007/s10072-015-2067-7
27 Wiesner W, Wetzel S, Kappos L. et al. Swallowing abnormalities in multiple sclerosis: Correlation between videofluoroscopy and subjective symptoms. Eur Radiol 2002; 12: 789-792 DOI:10.1007/s003300101086
28 Fernandes AMF, de Campos Duprat A, Eckley CA. et al. Oropharyngeal dysphagia in patients with multiple sclerosis: Do the disease classification scales reflect dysphagia severity?. Braz J Otorhinolaryngol 2013; 79: 460-465 DOI:10.5935/1808-8694.20130082
29 Terré-Boliart R, Orient-López F, Guevara-Espinosa D. et al Oropharyngeal dysphagia in patients with multiple sclerosis. Rev Neurol. 2004 39. 707-710 Im Internet: www.ncbi.nlm.nih.gov/pubmed/15514895 Stand: 17.05.2020
30 Solaro C, Cuccaro A, Gamberini G. et al. Prevalence of dysphagia in a consecutive cohort of subjects with MS using fibre-optic endoscopy. Neurological Sciences 2020; 41: 1075-1079 DOI:10.1007/s10072-019-04198-3
31 Mirmosayyeb O, Ebrahimi N, Shekarian A. et al. Prevalence of dysphagia in patients with multiple sclerosis: A systematic review and meta-analysis. Journal of Clinical Neuroscience 2023; 108: 84-94 DOI:10.1016/j.jocn.2023.01.006
32 Attrill S, White S, Murray J. et al. Impact of oropharyngeal dysphagia on healthcare cost and length of stay in hospital: A systematic review. BMC Health Serv Res 2018; 18: 594 DOI:10.1186/s12913-018-3376-3
33 Milewska M, Grabarczyk K, Dąbrowska-Bender M. et al. The prevalence and types of oral- and pharyngeal-stage dysphagia in patients with demyelinating diseases based on subjective assessment by the study subjects. Multiple Sclerosis and Related Disorders 2020; 37 DOI:101484. 10.1016/j.msard.2019.101484
34 Kai M, Matta C, Jalkh G. et al. Bulbar symptoms as an unusual presentation of multiple sclerosis: A case report. European Journal of Case Reports in Internal Medicine 2022; 9: 3377 DOI:10.12890/2022_003377
35 Kim Y, Shibli F, Fu Y. et al. Multiple sclerosis is associated with achalasia and diffuse esophageal spasm. Journal of Neurogastroenterology and Motility. 2023 DOI:10.5056/jnm22173
36 Eren F, Ozkan B, Demir A. The relationship between dysphagia, respiratory functions and anthropometry in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders 2021; 55: 103192 DOI:10.1016/j.msard.2021.103192
37 Tassorelli C, Bergamaschi R, Buscone S. et al. Dysphagia in multiple sclerosis: From pathogenesis to diagnosis. Neurol Sci 2008; 29: 360-363 DOI:10.1007/s10072-008-1044-9
38 Barzegar M, Mirmosayeb O, Rezaei M. et al. Prevalence and risk factors of dysphagia in patients with multiple sclerosis. Dysphagia 2022; 37: 21-27 DOI:10.1007/s00455-021-10245-z
39 Tahir E, Kavaz E, Kemal Ö. et al. Screening of dysphagia by DYMUS (Dysphagia in Multiple Sclerosis) and SWALQoL (Swallowing Quality of Life) surveys in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders 2020; 45: 102397 DOI:10.1016/j.msard.2020.102397
40 Sadeghi Z, Ghoreishi ZS, Flowers H. et al. Depression, anxiety, and stress relative to swallowing impairment in persons with multiple sclerosis. Dysphagia 2021; 36: 902-909 DOI:10.1007/s00455-020-10207-x
41 Ansari NN, Tarameshlu M, Ghelichi L. Dysphagia in multiple sclerosis patients: Diagnostic and evaluation strategies. Degenerative Neurological and Neuromuscular Disease 2020; 10: 15-28 DOI:10.2147/DNND.S198659
42 Bergamaschi R, Rezzani C, Minguzzi S. et al Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis. Funct Neurol. 2009 24. 159-162 Im Internet: https://pubmed.ncbi.nlm.nih.gov/20018144/ Stand: 17.11.2023
43 Renom M, Galán I, Vidal X. et al. Validation of the Spanish version of DYsphagia in MUltiple Sclerosis questionnaire (DYMUS). Multiple Sclerosis and Related Disorders 2023; 74: 104724 DOI:10.1016/j.msard.2023.104724
44 Sales DS, da Silva RG, Alvarenga RM. et al. Accuracy of the Brazilian version of the DYMUS questionnaire for the screening of oropharyngeal dysphagia in multiple sclerosis. Multiple Sclerosis and Related Disorders 2021; 50: 102772 DOI:10.1016/j.msard.2021.102772
45 Novotná K, Motýl J, Friedová L. et al. Validation of the Czech version of the Dysphagia in Multiple Sclerosis questionnaire (DYMUS). Dysphagia 2023; 38: 1087-1095 DOI:10.1007/s00455-022-10530-5
46 Vučković JB, Kolundžić Z, Šimunjak B. et al. DYMUS-Hr self-assessment questionnaire (Croatian version) for dysphagia in multiple sclerosis-validity, reliability, and cross-cultural adaptation. Neurological Sciences. 2023 DOI:10.1007/s10072-023-06850-5
47 Asadollahpour F, Mehri A, Khatoonabadi A. et al. Validation of the Persian version of the dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis. Journal of Research in Medical Sciences 2019; 24: 52 DOI:10.4103/jrms.JRMS_248_18
48 Printza A, Kalaitzi M, Bakirtzis C. et al. Reliability and validity of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis (Greek version) and proposed modification. Multiple Sclerosis and Related Disorders 2018; 23: 62-68 DOI:10.1016/j.msard.2018.05.004
49 Tenekeci EG, Kara B, Çetiz A. et al. Validity and reliability of the Turkish version of the questionnaire for the assessment of dysphagia in multiple sclerosis. Noro Psikiyatri Arsivi 2018; 55: 243-247 DOI:10.5152/npa.2016.18105
50 Villain M, Heinzlef O. DYMUS questionnaire for dysphagia in multiple sclerosis: French validation and clinical considerations. 2013. Im Internet: https://onlinelibrary.ectrims-congress.eu/ectrims/2013/copenhagen/34274/marie.villain.dymus.questionnaire.for.dysphagia.in.multiple.sclerosis.french.html Stand: 17.05.2023
51 Grasso MG, Gamberini G, Patti F. et al The dysphagia in multiple sclerosis questionnaire correlates with fiber-optic endoscopic examination for detecting swallowing deficits in MS. Dysphagia 2021; 36: 192-197 Im Internet: https://link.springer.com/10.1007/s00455-020-10119-w Stand: 27.11.2023
52 O’Neil KH, Purdy M, Falk J. et al. The dysphagia outcome and severity scale. Dysphagia 1999; 14: 139-145 DOI:10.1007/PL00009595
53 Printza A, Boziki M, Bakirtzis C. et al. The modified DYMUS questionnaire is a reliable, valid and easy-to-use tool in the assessment of dysphagia in multiple sclerosis. European Journal of Neurology 2020; 27: 1231-1237 DOI:10.1111/ene.14219
54 Bartolome G, Starrost U, Schröter-Morasch H. et al. Validation of the MUnich Swallowing Score (MUCSS) in patients with neurogenic dysphagia: A preliminary study. NeuroRehabilitation 2021; 49: 445-457 DOI:10.3233/NRE-210011
55 Eraković JL, Radulović LB, Idrizović ZA. et al. Screening of dysphagia in relapsing-remitting multiple sclerosis patients in Montenegro. Neurosciences 2021; 26: 331-338 DOI:10.17712/nsj.2021.4.20210063
56 Covello F, Ruoppolo G, Carissimo C. et al. Multiple sclerosis: Impact on oral hygiene, dysphagia, and quality of life. International Journal of Environmental Research and Public Health 2020; 17 DOI:10.3390/ijerph17113979
57 Tarameshlu M, Ghelichi L, Azimi AR. et al. The effect of traditional dysphagia therapy on the swallowing function in patients with multiple sclerosis: A pilot double-blinded randomized controlled trial. J Bodyw Mov Ther 2019; 23: 171-176 DOI:10.1016/j.jbmt.2018.01.016
58 Noë S, Goeleven A, Brouwers H. et al. Training for caregivers and compliance with dysphagia recommendations in a tertiary multiple sclerosis rehabilitation center. International Journal of MS Care 2021; 23: 223-228 DOI:10.7224/1537-2073.2020-019
59 Wirth AR, Dziewas R, Jäger M. et al. Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM): Klinische Ernährung in der Neurologie. 2013. Im Internet: www.awmf.org Stand: 27.11.2023
60 Grandidge L, Chotiyarnwong C, White S. et al. Survival following the placement of gastrostomy tube in patients with multiple sclerosis. Multiple Sclerosis Journal – Experimental, Translational and Clinical 2020; 6 2055217319900907 DOI:10.1177/2055217319900907
61 Alali D, Ballard K, Bogaardt H. Treatment effects for dysphagia in adults with multiple sclerosis: A systematic review. Dysphagia 2016; 31: 610-618 DOI:10.1007/s00455-016-9738-2
62 Tavakoli S, Poorjavad M, Taheri N. et al. Neuromuscular electrical stimulation in conjunction with conventional swallowing therapy in the treatment of dysphagia caused by multiple sclerosis: A single case experimental design. Folia Phoniatrica et Logopaedica. 2023 DOI:10.1159/000531062
63 Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V. Leitlinie Hypersalivation. 2018. Im Internet: www.awmf.org/leitlinien/detail/ll/017-075.html Stand: 27.11.2023
64 Runge J, Remmerbach TW. Xerostomie: Diagnostik und Therapie. ZWR Das Deutsche Zahnärzteblatt 2020; 129: 126-136 DOI:10.1055/a-1143-9944
65 Cosentino G, Gargano R, Bonura G. et al. Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: A pilot open-label study. Neurol Sci 2018; 39: 1471-1473 DOI:10.1007/s10072-018-3443-x
66 Duan H, Jing Y, Li Y. et al. Rehabilitation treatment of multiple sclerosis. Frontiers in Immunology 2023; 14: 1168821 DOI:10.3389/fimmu.2023.1168821
67 Maden T, Usgu G, Tuncer A. Myotonometric comparison of sternocleidomastoideus and masseter muscles in multiple sclerosis patients with swallowing problem and healthy individuals. Multiple Sclerosis and Related Disorders 2022; 57: 103387 DOI:10.1016/j.msard.2021.103387